ProQR Therapeutics N.V.
NASDAQ:PRQR
2.79 (USD) • At close December 27, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -27.543 | -64.891 | -61.68 | -46.614 | -56.746 | -37.086 | -43.524 | -39.119 | -20.831 | -12.127 | -3.253 |
| Depreciation & Amortization
| 2.461 | 2.521 | 2.329 | 2.355 | 2.052 | 0.992 | 1.065 | 1.245 | 0.48 | 0.126 | 0.024 |
| Deferred Income Tax
| -0.078 | 0.096 | 0.117 | 0.124 | 0.235 | 0.102 | 0.145 | 0.236 | 0.441 | 0.142 | 0.013 |
| Stock Based Compensation
| 3.106 | 2.869 | 6.216 | 7.838 | 9.108 | 3.224 | 4.024 | 2.454 | 1.212 | 0.646 | 0.041 |
| Change In Working Capital
| 48.956 | -5.434 | 24.995 | -5.011 | 1.783 | 1.294 | 0.164 | 1.433 | 0.637 | 1.09 | 0.829 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 48.956 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non Cash Items
| -5.355 | -3.669 | 2.011 | -5.752 | -0.402 | 0.792 | 3.175 | -0.47 | -6.171 | -4.334 | 0.014 |
| Operating Cash Flow
| 21.548 | -68.508 | -26.012 | -47.06 | -43.97 | -30.682 | -34.951 | -34.221 | -24.232 | -14.457 | -2.332 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -3.646 | -0.708 | -0.484 | -0.924 | -0.58 | -0.312 | -0.121 | -2.539 | -1.324 | -1.233 | -0.137 |
| Acquisitions Net
| 0.059 | 0.006 | 0.061 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 7.865 | 0 | -0.002 | 0 | 0 | 0 | 0 | 0 | -0.028 | 0 | 0 |
| Investing Cash Flow
| 4.278 | -0.702 | -0.425 | -0.924 | -0.58 | -0.312 | -0.121 | -2.539 | -1.324 | -1.233 | -0.137 |
| Financing Activities: | |||||||||||
| Debt Repayment
| -2.629 | -45.046 | 26.837 | 13.765 | 1.456 | 1.396 | 0.951 | 0.355 | 1.606 | 1.633 | 3.326 |
| Common Stock Issued
| 0.347 | 14.122 | 108.477 | 0.685 | 48.55 | 84.191 | 25.685 | 0.002 | 0.014 | 118.25 | 3.023 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.354 | 0.034 | 1.518 | 0.735 | 0.193 | 0.87 | 0.004 | 0.002 | 0.014 | 0 | 0 |
| Financing Cash Flow
| -2.275 | -30.89 | 136.832 | 14.5 | 50.199 | 88.646 | 26.64 | 0.357 | 1.62 | 119.883 | 6.349 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 0.599 | 7.351 | 1.291 | -2.628 | 0.721 | -0.171 | -2.669 | 0.738 | 6.065 | 4.414 | 0 |
| Net Change In Cash
| 24.15 | -92.749 | 111.686 | -36.112 | 6.37 | 57.481 | -11.101 | -35.665 | -17.871 | 108.607 | 3.88 |
| Cash At End Of Period
| 118.925 | 94.775 | 187.524 | 75.838 | 111.95 | 105.58 | 48.099 | 59.2 | 94.865 | 112.736 | 4.129 |